The impact of diagnosis of hepatitis C virus on quality of life
Lisa Forman M.D.
Center for Clinical Epidemiology and Biostatistics, Gastroenterology Division, University of Pennsylvania School of Medicine, Philadelphia, PA
Search for more papers by this authorSteven Kawut M.D.
Center for Clinical Epidemiology and Biostatistics Pulmonary and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA
Search for more papers by this authorIlene Rosen M.D.
Center for Clinical Epidemiology and Biostatistics Pulmonary and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA
Search for more papers by this authorGrace Pien M.D.
Center for Clinical Epidemiology and Biostatistics Pulmonary and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA
Search for more papers by this authorHillary Bogner M.D.
Center for Clinical Epidemiology and Biostatistics Family Practice and Community Medicine Division, Department of Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA
Search for more papers by this authorLisa Forman M.D.
Center for Clinical Epidemiology and Biostatistics, Gastroenterology Division, University of Pennsylvania School of Medicine, Philadelphia, PA
Search for more papers by this authorSteven Kawut M.D.
Center for Clinical Epidemiology and Biostatistics Pulmonary and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA
Search for more papers by this authorIlene Rosen M.D.
Center for Clinical Epidemiology and Biostatistics Pulmonary and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA
Search for more papers by this authorGrace Pien M.D.
Center for Clinical Epidemiology and Biostatistics Pulmonary and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, PA
Search for more papers by this authorHillary Bogner M.D.
Center for Clinical Epidemiology and Biostatistics Family Practice and Community Medicine Division, Department of Internal Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA
Search for more papers by this author
References
- 1 Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999; 30: 1299–1301.MEDLINE
- 2 Management of hepatitis C [Consensus Conference] Hepatology 1997; 26[Suppl]: 1S–155S.
- 1a Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999; 30: 1299–1301.MEDLINE
- 2a Rodger AJ, Thomson J, Thompson S, Jolley D, Mijch A, Lanigan A, Crofts N. Assessment of long term outcomes of hepatitis C virus infection in a cohort of patients with acute hepatitis in 1971-1975—results of a pilot study. J Gastroenterol Hepatol 1999; 14: 269–273.MEDLINE
- 3 Crofts N, Jolley D, Kaldor J, van Beek I, Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health 1997; 51: 692–697.MEDLINE
- 4 Crofts N, Aitken CK, Kaldor JM. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Med J Aust 1999; 170: 220–221.MEDLINE
